Autosomal dominant best vitelliform macular dystrophy (BVMD) or autosomal recessive bestrophinopathy (ARB) research hub

Bestrophin 1 treatment trial on the effectiveness of Ravicti

Researchers in Manchester are testing whether a medicine called Ravicti can help people with rare inherited eye conditions. These conditions damage cells at the back of the eye, causing sight loss. The study checks if taking Ravicti for one week improves how these eye cells work using simple electrical tests.